Viewing Study NCT04625595


Ignite Creation Date: 2025-12-24 @ 1:16 PM
Ignite Modification Date: 2026-02-03 @ 10:29 AM
Study NCT ID: NCT04625595
Status: COMPLETED
Last Update Posted: 2021-08-25
First Post: 2020-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes
Sponsor: Immunomolecular Therapeutics, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: IMT-002-0102
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View